Haemophilus Influenzae Type B: Clinical Trials

2 trials for Haemophilus Influenzae Type B, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2

Follow Haemophilus Influenzae Type B: new trials by email Literature Review of Haemophilus Influenzae Type B trials Research Report on Haemophilus Influenzae Type B

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks
Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval - Diphtheria, Tetanus
Not applicableCompletedVabiotech2222018-03-012019-05-03
Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya
SMS reminder, Travel subsidy, Travel subsidy 2 - Diphtheria, Tetanus
Not applicableCompletedJohns Hopkins Bloomberg School of Public Health20182013-10-012022-10-27

Narrower conditions

Diphtheria (2)  ·  Haemophilus Infections (2)  ·  Hepatitis B (2)  ·  Tetanus (2)  ·  Whooping Cough (2)  ·  Measles (1)

Broader conditions

Actinomycetales Infections (2)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Blood-Borne Infections (2)  ·  Bordetella Infections (2)  ·  Clostridium Infections (2)  ·  Communicable Diseases (2)  ·  Corynebacterium Infections (2)  ·  DNA Virus Infections (2)  ·  Digestive System Diseases (2)  ·  Gram-Negative Bacterial Infections (2)  ·  Gram-Positive Bacterial Infections (2)  ·  Hepadnaviridae Infections (2)  ·  Hepatitis (2)  ·  Hepatitis, Viral, Human (2)

Sponsors

Johns Hopkins Bloomberg School of Public Health (1)  ·  Vabiotech (1)

Countries

Kenya (1)  ·  Vietnam (1)

Results publications

PMID 28288747